Home › Epilepsy › Arkansas
Epilepsy clinical trials in Arkansas
3 studies for Epilepsy are looking for participants at sites in Arkansas.
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures
- Pillar Clinical Research, Bentonville
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Nov 12, 2026 · NCT07594119A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
- University of Arkansas for Medical Sciences, Little Rock
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Nov 2, 2026 · NCT05667142Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
- University of Arkansas for Medical Sciences, Little Rock
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Oct 30, 2026 · NCT05135091From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.